510(k) K261293
K261293 is an FDA 510(k) premarket notification submitted by EPS Bio Technology Corp. for the device "EASYMAX Voice Blood Glucose Monitoring System". The FDA issued a decision of Substantially Equivalent on Oct 23, 2026. The device falls under product code NBW (System, Test, Blood Glucose, Over The Counter), a Class II device regulated under 21 CFR 862.1345. EPS Bio Technology Corp. has 24 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Oct 23, 2026
- Date Received
- Apr 20, 2026
- Clearance Type
- Special
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- System, Test, Blood Glucose, Over The Counter
- Device Class
- Class II
- Regulation Number
- 862.1345
- Review Panel
- CH
- Submission Type
- 510(k)